Edyta Szymanska Selected Research

Biomarkers (Surrogate Marker)

1/2023	Biological markers of disease activity in inflammatory bowel diseases.
4/2022	New non-invasive biomarkers of intestinal inflammation and increased intestinal permeability in pediatric inflammatory bowel diseases and their correlation with fecal calprotectin: a pilot study.
8/2021	Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases-Correlation with Disease Activity and Fecal Calprotectin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edyta Szymanska Research Topics

Disease

7	Crohn Disease (Crohn's Disease) 04/2022 - 05/2012
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 07/2021
4	Inflammation (Inflammations) 01/2023 - 01/2016
2	Ulcerative Colitis 04/2022 - 01/2018
1	Colitis 01/2023
1	Glycogen Storage Disease (Glycogenosis) 12/2021
1	Tyrosinemias (Tyrosinemia) 12/2015
1	Pediatric Crohn's disease 01/2015
1	Gastroesophageal Reflux (GERD) 05/2014

Drug/Important Bio-Agent (IBA)

5	Infliximab (Remicade)FDA Link 07/2021 - 05/2012
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023 - 08/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2015
2	zonulinIBA 04/2022 - 08/2021
2	Adalimumab (Humira)FDA Link 01/2017 - 01/2015
2	Monoclonal AntibodiesIBA 01/2015 - 01/2015
1	CarbohydratesIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Glucose-6-PhosphateIBA 12/2021
1	vedolizumabIBA 07/2021
1	DioxygenasesIBA 12/2015
1	Tyrosine (L-Tyrosine)FDA Link 12/2015
1	Proton Pump InhibitorsIBA 05/2014

Therapy/Procedure

4	Therapeutics 01/2018 - 05/2012
4	Biological Therapy 01/2017 - 01/2015
1	Premedication 07/2021
1	Remission Induction 01/2016